What is Capricor Therapeutics's pre-tax income?

Capricor Therapeutics (CAPR) reported pre-tax income of -$33.94M in Q1 2026.

How has Capricor Therapeutics's pre-tax income changed year-over-year?

Capricor Therapeutics's pre-tax income decreased by 39.2% year-over-year, from -$24.39M to -$33.94M.

What does pre-tax income mean?

Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.

Capricor Therapeutics CAPR Pre-Tax Income

Pre-Tax Income at other companies

PfizerPFE

$3.17B+13.8%

PTC TherapeuticsPTCT

-$2.46M-100%

LeMaitre VascularLMAT

$19.67M+38.1%

Catalyst PharmaceuticalCPRX

$84.23M+18.2%

CelcuityCELC

-$52.84M-42.8%

MedtronicMDT

$1.83B+45.4%

Segments

By segment

See full

Single Reportable-$33.94M-39.2%

Other financials

Income statement

See full

Revenue--100%

Operating income-$36.8M-47.2%

Net income-$33.9M-39.2%

EPS (diluted)-$0.59-11.3%

Balance sheet

See full

Cash & equivalents$105.4M+266%

Total debt$14.8M+1,083%

Total equity$278.7M+118%

Total assets$326.3M+112%

Cash flow

See full

Operating cash flow-$29.3M-355%

CapEx$5.1M+472%

Free cash flow-$34.4M-369%

Valuation

See full

Market cap$1.71B+303%

Profitability

See full

Operating margin-778.8%-1,038pp

Net margin-736.6%-981pp

FCF margin-563.9%-954pp

Returns & leverage

See full

Return on equity-56.4%-11.3pp

Debt / equity0.1×0.0×

Current ratio8.4×+1.9×

Where this comes from

Reported directly by Capricor Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.

The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Capricor Therapeutics's pre-tax income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Capricor Therapeutics's pre-tax income?: Capricor Therapeutics (CAPR) reported pre-tax income of -$33.94M in Q1 2026.
How has Capricor Therapeutics's pre-tax income changed year-over-year?: Capricor Therapeutics's pre-tax income decreased by 39.2% year-over-year, from -$24.39M to -$33.94M.
What does pre-tax income mean?: Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.